REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Alcoholic Liver Cirrhosis
Interventions
BIOLOGICAL

Livercellgram

"Livercellgram~* Dosage form and appearance: White cell suspension is filled in a clear plastic syringe, and fixed with an occlude on the prefilled syringe tip ② Component: Autologous bone marrow-derived mesenchymal stem cell ③ Amount: 5X107 cells, 1-time or 2-time injection ④ Storage Method: Stored in airtight container at 20\~25℃~ * Injection Method: Directly inject into liver through hepatic artery"

Trial Locations (1)

Unknown

Pharmicell Co., Ltd., Seoul

All Listed Sponsors
lead

Pharmicell Co., Ltd.

INDUSTRY

NCT01875081 - REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient) | Biotech Hunter | Biotech Hunter